Ontvang nu dagelijks onze kooptips!

word abonnee
Van beleggers
voor beleggers
desktop iconMarkt Monitor
  • Word abonnee
  • Inloggen

    • Geen account? Registreren

    Wachtwoord vergeten?

Aandeel Novacyt PSE:ALNOV.FR, FR0010397232

Laatste koers (eur) Verschil Volume
0,544   -0,014   (-2,51%) Dagrange 0,537 - 0,558 12.716   Gem. (3M) 283,7K

Novacyt de volgende biotech raket!

70.500 Posts
Pagina: «« 1 ... 1803 1804 1805 1806 1807 ... 3525 »» | Laatste | Omlaag ↓
  1. [verwijderd] 9 november 2020 14:39
    www.sharebuyers.co.uk/shares/covid-19...

    Our View
    While promising, this does not mean a COVID-19 vaccine is immediately present or in sight. However, we’d expect news of a COVID-19 vaccine to continue to ramp up in the coming weeks and months which will naturally boost the markets and detract from those who have significant immediate potential from testing for COVID-19.

    Investors who are spooked by the falls in share price must ask themselves how well their investments are positioned to survive such conditions and the value of their wider propositions.

    For example, we know the likes of Novacyt have a huge cash pile and the question is what it will do with it next. We know EKF has a solid and reliable business model regardless of COVID-19.

    We also know that today’s COVID-19 testing stock crash could also be reversed with news of big orders as financials are hard to argue against.
70.500 Posts
Pagina: «« 1 ... 1803 1804 1805 1806 1807 ... 3525 »» | Laatste |Omhoog ↑

Meedoen aan de discussie?

Word nu gratis lid of log in met je emailadres en wachtwoord.